Epidemiological Considerations in Male Infertility

Chapter

Abstract

The diagnosis of male infertility indicates impairment in male reproductive potential. Unfortunately, there is no gold standard test for assessing male reproductive potential. The diagnostic accuracy of semen analysis is compromised by substantial overlap between the distributions of semen characteristics in empirically fertile and infertile men. Novel assays, including seminal reactive oxygen species levels, may prove to be of greater clinical utility for identifying men with below-average reproductive potential. Efforts to identify and treat modifiable risk factors should ideally be targeted toward these individuals. Although economic analyses have demonstrated that pathology-directed treatment for male infertility is often more cost-effective than immediate use of assisted reproductive technology, there is a declining trend in surgical treatment of male infertility.

Keywords

Male infertility Incidence and prevalence of infertility Infertility in developing world Epidemiology of infertility Reactive oxygen species Novel diagnostic assays Semen studies 

Notes

Acknowledgments

The author would like to thank Kelli M. Mulder-Westrate and Ranya N. Sweis for critically reviewing several drafts of this chapter and offering helpful advice. Jonathan L. Faasse and Kristin M. Faasse provided valuable assistance with the figures.

References

  1. 1.
    Tremellen K. Oxidative stress and male infertility—a clinical perspective. Hum Reprod Update. 2008;14:243–58.PubMedCrossRefGoogle Scholar
  2. 2.
    Sharma RK, Said T, Agarwal A. Sperm DNA damage and its clinical relevance in assessing reproductive outcome. Asian J Androl. 2004;6:139–48.PubMedGoogle Scholar
  3. 3.
    Athayde KS, Cocuzza M, Agarwal A, et al. Development of normal reference values for seminal reactive oxygen species and their correlation with leukocytes and semen parameters in a fertile population. J Androl. 2007;28:613–20.PubMedCrossRefGoogle Scholar
  4. 4.
    Agarwal A, Sharma RK, Nallella KP, Thomas AJ, Alvarez JG, Sikka SC. Reactive oxygen species as an independent marker of male factor infertility. Fertil Steril. 2006;86:878–85.PubMedCrossRefGoogle Scholar
  5. 5.
    Lumley J. Epidemiological approaches to infertility. Reprod Fertil Dev. 1998;10:17–21.PubMedCrossRefGoogle Scholar
  6. 6.
    Alukal JP, Lipshultz LI. Why treat the male in the era of assisted reproduction? Semin Reprod Med. 2009;27:109–14.PubMedCrossRefGoogle Scholar
  7. 7.
    Habbema JDF, Collins J, Leridon H, Evers JLH, Lunenfeld B, te Velde ER. Towards less confusing terminology in reproductive medicine: a proposal. Hum Reprod. 2004;19:1497–501.PubMedCrossRefGoogle Scholar
  8. 8.
    Davies MJ, De Lacey SL, Norman RJ. Towards less confusing terminology in reproductive medicine: clarifying medical ambiguities to the benefit of all. Hum Reprod. 2005;20:2669–71.PubMedCrossRefGoogle Scholar
  9. 9.
    Greenhall E, Vessey M. The prevalence of subfertility: a review of the current confusion and a report of two new studies. Fertil Steril. 1990;54:978–83.PubMedGoogle Scholar
  10. 10.
    Rowe PJ, Comhaire FH, Hargreave TB, Mahmoud AMA. WHO manual for the standardized investigation, diagnosis and management of the infertile male. New York, NY: Cambridge University Press; 2000.Google Scholar
  11. 11.
    Sigman M, Jarow JP. Male infertility. In: Wein AJ, Kavoussi LR, et al., editors. Campbell-Walsh urology. 9th ed. Philadelphia, PA: Saunders Elsevier; 2007. p. 609–53.Google Scholar
  12. 12.
    Simpson JL, Jauniaux ERM. Pregnancy loss. In: Gabbe SG, Niebyl JR, Simpson JL, editors. Obstetrics: normal and problem pregnancies. 5th ed. Philadelphia, PA: Churchill Livingstone Elsevier; 2007. p. 628–49.CrossRefGoogle Scholar
  13. 13.
    Stephen EH, Chandra A. Declining estimates of infertility in the United States: 1982–2002. Fertil Steril. 2006;86:516–23.PubMedCrossRefGoogle Scholar
  14. 14.
    te Velde ER, Eijkemans R, Habbema HDF. Variation in couple fecundity and time to pregnancy, an essential concept in human reproduction. Lancet. 2000;355:1928–9.CrossRefGoogle Scholar
  15. 15.
    Rutstein SO, Shah IH. Infecundity, infertility, and childlessness in developing countries. DHS Comparative Reports No. 9. Calverton, MD: ORC Macro and the World Health Organization; 2004.Google Scholar
  16. 16.
    Lunenfeld B, van Steirteghem A. Infertility in the third millennium: implications for the individual, family and society: condensed meeting report from the Bertarelli Foundation’s Second Global Conference. Hum Reprod Update. 2004;10:317–26.PubMedCrossRefGoogle Scholar
  17. 17.
    Kefer JC, Agarwal A, Sabanegh E. Role of antioxidants in the treatment of male infertility. Int J Urol. 2009;16:449–57.PubMedCrossRefGoogle Scholar
  18. 18.
    van Noord-Zaadstra BM, Looman CWN, Alsbach H, Habbema JDF, te Velde ER, Karbaat J. Delaying childbearing: effect of age on fecundity and outcome of pregnancy. BMJ. 1991;302:1361–5.PubMedCrossRefGoogle Scholar
  19. 19.
    Ford WCL, North K, Taylor H, Farrow A, Hull MGR, Golding J. Increasing paternal age is associated with delayed conception in a large population of fertile couples: evidence for declining fecundity in older men. The ALSPAC Study Team. Hum Reprod. 2000;15: 1703.PubMedCrossRefGoogle Scholar
  20. 20.
    Evers JLH. Female subfertility. Lancet. 2002;350:151–9.CrossRefGoogle Scholar
  21. 21.
    Spira A. Epidemiology of human reproduction. Hum Reprod. 1986;1:111–5.PubMedGoogle Scholar
  22. 22.
    Leridon H, Spira A. Problems in measuring the effectiveness of infertility therapy. Fertil Steril. 1984;41:580–6.PubMedGoogle Scholar
  23. 23.
    Evers JL, te Velde ER. Vruchtbaarheidsstoornissen. In: Heineman MJ, Bleker OP, Evers JL, Heintz AP, editors. Obstetrie en Gynaecologie, de voortplanting van de mens. Maarssen: Elsevier Science; 2001. p. 435–71.Google Scholar
  24. 24.
    Bongaarts J. A method for estimation of fecundability. Demography. 1975;12:645–60.PubMedCrossRefGoogle Scholar
  25. 25.
    Dunson DB, Colombo B, Baird DD. Changes with age in the level and duration of fertility in the menstrual cycle. Hum Reprod. 2002;17:1399–403.PubMedCrossRefGoogle Scholar
  26. 26.
    Gnoth C, Godehardt D, Godehardt E, Frank-Herrmann PF, Freundl G. Time to pregnancy: results of the German prospective study and impact on the management of infertility. Hum Reprod. 2003;188: 1959–66.CrossRefGoogle Scholar
  27. 27.
    Sharlip ID, Jarow JP, Belker AM, et al. Best practice policies for male infertility. Fertil Steril. 2002;77:873–82.PubMedCrossRefGoogle Scholar
  28. 28.
    Muller CH. Rationale, interpretation, validation, and uses of sperm function tests. J Androl. 2000;21:10–30.PubMedGoogle Scholar
  29. 29.
    Kobayashi H, Gil-Guzman E, Mahran AM, et al. Quality control of reactive oxygen species measurement by luminol-dependent chemiluminescence assay. J Androl. 2001;22:568–74.PubMedGoogle Scholar
  30. 30.
    Barratt CLR, Aitken RJ, Björndahl L, et al. Sperm DNA: organization, protection and vulnerability: from basic science to clinical applications—a position report. Hum Reprod. 2010;25:824–38.PubMedCrossRefGoogle Scholar
  31. 31.
    Menkveld R. Clinical significance of the low normal sperm morphology value as proposed in the fifth edition of the WHO Laboratory Manual for the Examination and Processing of Human Semen. Asian J Androl. 2010;12:47–58.PubMedCrossRefGoogle Scholar
  32. 32.
    Cooper TG, Noonan E, von Eckardstein S, et al. World Health Organization reference values for human semen characteristics. Hum Reprod Update. 2010;16:231–45.PubMedCrossRefGoogle Scholar
  33. 33.
    Guzick DS, Overstreet JW, Factor-Litvak P, et al.; for the National Cooperative Reproductive Medicine Network. Sperm morphology, motility, and concentration in fertile and infertile men. NEJM. 2001; 345:1388–93.Google Scholar
  34. 34.
    Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem. 1993;39:561–77.PubMedGoogle Scholar
  35. 35.
    MacLeod J. Semen quality in one thousand men of known fertility and in eight hundred cases of infertile marriage. Fertil Steril. 1951;2:115–39.PubMedGoogle Scholar
  36. 36.
    Niederberger CS. Understanding the epidemiology of fertility treatments. Urol Clin North Am. 2002;29:829–40.PubMedCrossRefGoogle Scholar
  37. 37.
    Ombelet W, Bosmans E, Janssen M, et al. Semen parameters in a fertile versus subfertile population: a need for change in the interpretation of semen testing. Hum Reprod. 1997;12:987–93.PubMedCrossRefGoogle Scholar
  38. 38.
    Gunalp S, Onculoglu C, Gurgan T, Kruger TF, Lombard CJ. A study of semen parameters with emphasis on sperm morphology in a fertile population: an attempt to develop clinical thresholds. Hum Reprod. 2001;16:110–4.PubMedCrossRefGoogle Scholar
  39. 39.
    Menkveld R, Wong WY, Lombard CJ, et al. Semen parameters, including WHO and strict criteria morphology, in a fertile and subfertile population: an effort towards standardization of in-vivo thresholds. Hum Reprod. 2001;16:1165–71.PubMedCrossRefGoogle Scholar
  40. 40.
    Jedrzejczak P, Taszarek-Hauke G, Hauke J, Pawelczyk L, Duleba AJ. Prediction of spontaneous conception based on semen parameters. Int J Androl. 2008;31:499–507.PubMedCrossRefGoogle Scholar
  41. 41.
    van der Merwe FH, Kruger TF, Oehninger SC, Lombard CJ. The use of semen parameters to identify the subfertile male in the general population. Gynecol Obstet Invest. 2005;59:86–91.PubMedCrossRefGoogle Scholar
  42. 42.
    Zinaman MJ, Brown CC, Selevan SG, Clegg ED. Semen quality and human fertility: a prospective study with healthy couples. J Androl. 2000;21:145–53.PubMedGoogle Scholar
  43. 43.
    Bonde JPE, Ernst E, Jensen TK, et al. Relation between semen quality and fertility: a population-based study of 430 first-pregnancy planners. Lancet. 1998;352:1172–7.PubMedCrossRefGoogle Scholar
  44. 44.
    Skakkebaek N. Normal reference ranges for semen quality and their relations to fecundity. Asian J Androl. 2010;12:95–8.PubMedCrossRefGoogle Scholar
  45. 45.
    Leushuis E, van der Steeg JW, Steures P, et al. Prediction models in reproductive medicine: a critical appraisal. Hum Reprod Update. 2009;15:537–52.PubMedCrossRefGoogle Scholar
  46. 46.
    van der Steeg JW, Steures P, Eijkemans MJC, et al. Pregnancy is predictable: a large-scale prospective external validation of the prediction of spontaneous pregnancy in subfertile couples. Hum Reprod. 2007;22:536–42.PubMedCrossRefGoogle Scholar
  47. 47.
    Zorn B, Vidmar G, Meden-Vrtovec H. Seminal reactive oxygen species as predictors of fertilization, embryo quality and pregnancy rates after conventional in vitro fertilization and intracytoplasmic sperm injection. Int J Androl. 2003;26:279–85.PubMedCrossRefGoogle Scholar
  48. 48.
    Mercan R, Lanzendorf SE, Mayer J, Nassar A, Muasher SJ, Oehninger S. The outcome of clinical pregnancies following intracytoplasmic sperm injection is not affected by semen quality. Andrologia. 1998;30:91–5.PubMedCrossRefGoogle Scholar
  49. 49.
    Ombelet W, Deblaere K, Bosmans E, et al. Semen quality and intrauterine insemination. Reprod Biomed Online. 2003;7:485–92.PubMedCrossRefGoogle Scholar
  50. 50.
    Allamaneni SS, Bandaranayake I, Agarwal A. Use of semen quality scores to predict pregnancy rates in couples undergoing intrauterine insemination with donor sperm. Fertil Steril. 2004;82:606–11.PubMedCrossRefGoogle Scholar
  51. 51.
    Shibahara H, Obara H, Ayustawati, et al. Prediction of pregnancy by intrauterine insemination using CASA estimates and strict criteria in patients with male factor infertility. Int J Androl. 2004; 27:63–8.Google Scholar
  52. 52.
    Aitken RJ. Whither must spermatozoa wander? The future of laboratory seminology. Asian J Androl. 2010;12:99–103.PubMedCrossRefGoogle Scholar
  53. 53.
    Deepinder F, Chowdary HT, Agarwal A. Role of metabolomic analysis of biomarkers in the management of male infertility. Expert Rev Mol Diagn. 2007;7:351–8.PubMedCrossRefGoogle Scholar
  54. 54.
    Desai N, Sharma R, Makker K, Sabanegh E, Agarwal A. Physiologic and pathologic levels of reactive oxygen species in neat semen of infertile men. Fertil Steril. 2009;92:1626–31.PubMedCrossRefGoogle Scholar
  55. 55.
    Carlsen E, Giwercman A, Keiding N, Skakkebaek NE. Evidence for decreasing quality of semen during past 50 years. BMJ. 1992;305:609–13.PubMedCrossRefGoogle Scholar
  56. 56.
    de Kretser DM. Declining sperm counts: environmental chemicals may be to blame. BMJ. 1996;312:457–8.PubMedCrossRefGoogle Scholar
  57. 57.
    Sharpe RM, Skakkebaek NE. Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet. 1993;341:1392–5.PubMedCrossRefGoogle Scholar
  58. 58.
    Fisch H. Declining worldwide sperm counts: disproving a myth. Urol Clin N Am. 2008;35:137–46.CrossRefGoogle Scholar
  59. 59.
    Sherins RJ. Are semen quality and male fertility changing? NEJM. 1995;332:327–8.PubMedCrossRefGoogle Scholar
  60. 60.
    Fisch H, Goluboff ET. Geographic variations in sperm counts: a potential cause of bias in studies of semen quality. Fertil Steril. 1996;65:1044–6.PubMedGoogle Scholar
  61. 61.
    Fisch H, Goluboff ET, Olson JH, Feldshuh J, Broder SJ, Barad DH. Semen analyses in 1,283 men from the United States over a 25-year period: no decline in quality. Fertil Steril. 1996;65:1009–14.PubMedGoogle Scholar
  62. 62.
    Saidi JA, Chang DT, Goluboff ET, Bagiella E, Olsen G, Fisch H. Declining sperm counts in the United States? A critical review. J Urol. 1999;161:460–2.PubMedCrossRefGoogle Scholar
  63. 63.
    Niederberger CS, Joyce GF, Wise M, Meacham RB. Male infertility. In: Litwin MS, Saigal CS, editors. Urologic diseases in America. US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Washington, DC: U.S. Government Printing Office; 2007, NIH Publication No. 07-5512. p. 461–81.Google Scholar
  64. 64.
    Centers for Disease Control and Prevention (CDC), American Society for Reproductive Medicine, Society for Assisted Reproductive Technology. 2007 assisted reproductive technology success rates: national summary and fertility clinic reports. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2009.Google Scholar
  65. 65.
    Wright VC, Schieve LA, Reynolds MA, Jeng G. Assisted reproductive technology surveillance—United States, 2000. MMWR Surveill Summ. 2003;52(No. SS-9):1–16.PubMedGoogle Scholar
  66. 66.
    Drummond MF, Schulpher MJ, Torrance GW, O’Brien BJ, Stoddart GL. Methods for the economic evaluation of health care programmes. 3rd ed. New York, NY: Oxford University Press; 2005. p. 277–322.Google Scholar
  67. 67.
    Shin D, Honig SC. Economics of treatments for male infertility. Urol Clin N Am. 2002;29:841–53.CrossRefGoogle Scholar
  68. 68.
    Robb P, Sandlow JI. Cost-effectiveness of vasectomy reversal. Urol Clin N Am. 2009;36:391–6.CrossRefGoogle Scholar
  69. 69.
    Lee R, Li PS, Goldstein M, Schattman G, Schlegel PN. A decision analysis of treatments for nonobstructive azoospermia associated with varicocele. Fertil Steril. 2009;92:188–96.PubMedCrossRefGoogle Scholar
  70. 70.
    Penson DF, Paltiel AD, Krumholz HM, Palter S. The cost-effectiveness of treatment for varicocele related infertility. J Urol. 2002;168: 2490–4.PubMedCrossRefGoogle Scholar
  71. 71.
    Meng MV, Greene KL, Turek PJ. Surgery or assisted reproduction? A decision analysis of treatment costs in male infertility. J Urol. 2005;174:1926–31.PubMedCrossRefGoogle Scholar
  72. 72.
    Hsieh MH, Meng MV, Turek PJ. Markov modeling of vasectomy reversal and ART for infertility: how do obstructive interval and female partner age influence cost effectiveness? Fertil Steril. 2007;88:840–6.PubMedCrossRefGoogle Scholar
  73. 73.
    Esteves SC, Oliveira FV, Bertolla RP. Clinical outcome of intracytoplasmic sperm injection in infertile men with treated and untreated clinical varicocele. J Urol. 2010;184:1442–6.PubMedCrossRefGoogle Scholar
  74. 74.
    Boyd JC. Defining laboratory reference values and decision limits: populations, intervals, and interpretations. Asian J Androl. 2010;12:83–90.PubMedCrossRefGoogle Scholar
  75. 75.
    Niederberger C. Responses to semen analysis CART report. J Androl. 2003;24:329–31.PubMedGoogle Scholar
  76. 76.
    Thompson IM, Ankerst DP, Etzioni R, Wang T. It’s time to abandon an upper limit of normal for prostate specific antigen: assessing the risk of prostate cancer. J Urol. 2008;180:1218–22.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Department of UrologyUniversity of Illinois at ChicagoChicagoUSA
  2. 2.Department of UrologyUniversity of Illinois at Chicago College of Medicine and Department of Bioengineering, University of Illinois at Chicago College of EngineeringChicagoUSA

Personalised recommendations